WHOOP raises $575 million in Series G funding with major GCC expansion

Health wearable company WHOOP has secured $575 million in Series G funding at a $10.1 billion valuation, marking a strategic push into the GCC with substantial backing from regional investors.

According to WHOOP's official announcement, the round attracted major participation from Qatar Investment Authority, Mubadala Investment Company, and 2PointZero Group, as well as individual investors Cristiano Ronaldo and Karen Wazen.

GCC investors fuel record valuation

The Series G round, led by Collaborative Fund, represents a significant strategic shift toward the GCC market. Major regional sovereign wealth funds—Qatar Investment Authority and Mubadala Investment Company—joined alongside regional investment firm 2PointZero Group. Global investors include Abbott, Mayo Clinic, Macquarie Capital, and several others.

Individual investors demonstrate WHOOP's growing cultural relevance across the region. Cristiano Ronaldo, who has strong ties to the GCC, participated alongside UAE-based influencer Karen Wazen. The roster also includes LeBron James, Rory McIlroy, and other global figures, underscoring the platform's appeal to elite performers.

This funding positions WHOOP among the highest-valued digital health platforms globally, reflecting investor confidence in the subscription-based wearable model.

What this means for the regional health-tech landscape

There is a straightforward way to understand WHOOP's GCC focus: the region represents one of the world's most forward-looking markets for health and performance technology. Previously, international health-tech companies viewed the GCC as a secondary market. WHOOP has changed this by treating the region as a strategic growth hub deserving of dedicated infrastructure.

The value chain here is divided into three parts: device manufacturing, data processing, and health insights delivery. WHOOP has integrated the latter two whilst modularising hardware production, creating a defensible position through data network effects. The more members use WHOOP, the better its AI models become, which attracts more users—a virtuous cycle that explains premium valuations in this space.

By extension, this means WHOOP's investment in WHOOP Labs Doha isn't just about regional expansion—it's about owning the customer relationship in a high-value market whilst building local research capabilities.

WHOOP Labs Doha: First international R&D facility

WHOOP will open WHOOP Labs Doha in the coming months, marking its first international performance research and development facility. This represents more than a symbolic commitment—it signals genuine infrastructure investment in the region's evolving performance science ecosystem.

The facility will support WHOOP's broader GCC expansion, including advancing initiatives across the UAE and Qatar to accelerate adoption. The company is expanding local teams and growing its retail footprint across multiple regional markets.

"The GCC is one of the most forward-looking regions in the world when it comes to health, performance and longevity," said Will Ahmed, WHOOP's Founder and CEO. "We're building real momentum on the ground, expanding our local teams and growing our retail footprint in multiple markets."

The business model behind the valuation

WHOOP operates on a membership model rather than traditional device sales, creating recurring revenue streams that justify premium valuations. The company now has over 2.5 million members worldwide, with bookings growing 103% year-over-year in 2025, exiting at a $1.1 billion run rate.

The platform's stickiness drives engagement: members open the app more than 8 times per day—almost 3 times as often as with other screenless wearables. This engagement feeds WHOOP's AI models, which analyse over 24 billion hours of physiological data to deliver personalised health insights.

Cristiano Ronaldo, now a WHOOP investor and global ambassador, explained his participation: "WHOOP has become one of the most important tools I use to support my long-term health. I am proud to participate in this round because I believe in the future we are building together."

The company achieved cash-flow-positive operations in 2025 and is hiring for over 600 new roles globally to support international expansion.

Looking forward: Market consolidation implications

Looking forward, this suggests the health wearable market is consolidating around platforms that can demonstrate genuine health outcomes rather than basic fitness tracking. WHOOP's FDA-cleared ECG, Healthspan longevity feature, and Advanced Labs blood biomarker analysis differentiate it from traditional fitness trackers.

WHOOP plans to use Series G proceeds to fuel international expansion across the GCC, Europe, Latin America, and Asia. The company currently ships to 56 countries and operates in six languages.

Frequently Asked Questions

How much funding did WHOOP raise?

WHOOP raised $575 million in Series G funding at a $10.1 billion valuation. The round was led by Collaborative Fund with strong participation from GCC-based investors.

Which GCC investors participated in WHOOP's funding round?

Major GCC investors include Qatar Investment Authority (QIA), Mubadala Investment Company, and 2PointZero Group. Individual investors with regional ties include Cristiano Ronaldo and Karen Wazen.

What is WHOOP Labs Doha?

WHOOP Labs Doha will be WHOOP's first international performance research and development facility, opening in Qatar in the coming months as part of the company's GCC expansion strategy.

Is WHOOP expanding in the UAE?

Yes, WHOOP is scaling its presence across the GCC, including advancing initiatives in the UAE and Qatar to accelerate adoption. The company is expanding local teams and growing its retail footprint.

What makes WHOOP different from other fitness trackers?

WHOOP operates on a membership model with advanced health features including FDA-cleared ECG, Healthspan longevity tracking, and blood biomarker analysis, positioning it as a comprehensive health platform rather than basic fitness tracker.

Written by

Share

Copied